semaglutide heart problems cardiovascular outcomes align more closely with attained dose than achieved weight loss We've recommended semaglutide (Wegovy) on

Mast cells in the skin degranulate in response to the injected medication, releasing histamine that activates nerve endings and creates that maddening itch

Implications for practice Most of the people we support with type 2 diabetes and CKD will already have received optimal therapy with the highest tolerated and licensed dose of ACE inhibitor/ARB and an SGLT2 inhibitor, and many will also be prescribed finerenone

This means the results actually improve over time, which is a significant advantage for post-weight-loss patients concerned about skin laxity

Dehydration concentrates stool and makes bowel movements harder

B12 deficiency, when present, can worsen hair loss

Peptides (2018) 100:4853